Economic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system

BACKGROUND: Breast cancer is treated with many different modalities, including chemotherapy that can be given as a single agent or in combination. Patients often experience adverse events from chemotherapy during the cycles of treatment which can lead to economic burden. OBJECTIVE: The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashid, Nazia, Koh, Han A, Baca, Hilda C, Lin, Kathy J, Malecha, Susan E, Masaquel, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063632/
https://www.ncbi.nlm.nih.gov/pubmed/27785099
http://dx.doi.org/10.2147/BCTT.S105618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063632/
https://www.ncbi.nlm.nih.gov/pubmed/27785099
http://dx.doi.org/10.2147/BCTT.S105618

Ejemplares similares